首页> 外文期刊>Modern Pathology >Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
【24h】

Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors

机译:SDHA表达的丧失预示着胃肠道间质瘤中的SDHA突变

获取原文
       

摘要

Gastrointestinal stromal tumors (GISTs) are usually driven by mutations in KIT or PDGFRA, although 15% of GISTs in adults and >90% in children lack such mutations. The majority of gastric KIT/PDGFRA wild-type GISTs show distinctive morphological and clinical features and loss of expression of succinate dehydrogenase (SDH) B. Only a small subset of SDHB-deficient GISTs carries loss-of-function mutations in SDHB, SDHC, or SDHD. Because of the complexity of its locus (15 exons) and the presence of three pseudogenes, SDHA is rarely analyzed. Recently, mutations in SDHA were shown to lead to loss of expression of SDHA in a small group of paragangliomas. We sought to determine whether immunohistochemistry for SDHA could identify GISTs with SDHA mutations. Tumors (n=33) with pathological features of SDH-deficient GIST were analyzed for expression of SDHA and SDHB by immunohistochemistry, and SDHA exons were sequenced from tumors lacking SDHA expression. Exons harboring somatic mutations were examined in DNA from corresponding normal tissue. All 33 tumors showed loss of SDHB expression. A total of 9 out of 33 (27%) tumors also lacked expression of SDHA. SDHA-deficient GISTs affected five men and four women (median age 38 years). SDHA expression was intact in the 24 remaining tumors, including those with known SDHB (n=3) or SDHC (n=2) mutations. Nonsense (n=8) or missense (n=1) mutations in SDHA were identified in all SDHA-deficient tumors. Heterozygous mutations were also found in DNA from normal tissues from six patients with available material. Somatic loss of the second allele has been found in seven tumors, five by loss of heterozygosity, one by a 13-bp deletion, and one by a missense mutation. Loss of SDHA expression in GIST reliably predicts the presence of SDHA mutations, which represent a relatively common cause of SDH-deficient GIST in adults. Immunohistochemistry for SDHA can be used to select patients for SDHA-specific genetic testing.
机译:胃肠道间质瘤(GIST)通常是由KIT或PDGFRA突变驱动的,尽管成年人中15%的GIST和儿童中的90%以上的GIST缺乏这种突变。大部分的胃KIT / PDGFRA野生型GIST表现出独特的形态和临床特征以及琥珀酸脱氢酶(SDH)B的表达缺失。只有一小部分SDHB缺陷型GIST在SDHB,SDHC,或SDHD。由于其基因座(15个外显子)的复杂性和三个假基因的存在,很少对SDHA进行分析。最近,在少数副神经节瘤中,SDHA的突变被证明可导致SDHA表达的丧失。我们试图确定SDHA的免疫组织化学是否可以鉴定具有SDHA突变的GIST。通过免疫组织化学分析了具有SDH缺陷型GIST病理特征的肿瘤(n = 33)中SDHA和SDHB的表达,并从缺乏SDHA表达的肿瘤中测序出SDHA外显子。检查来自相应正常组织的DNA中携带体细胞突变的外显子。所有33例肿瘤均显示SDHB表达缺失。 33个肿瘤中总共9个(27%)也缺乏SDHA表达。缺乏SDHA的GIST感染了5名男性和4名女性(中位年龄38岁)。在剩下的24个肿瘤中,SDHA表达是完整的,包括那些具有已知SDHB(n = 3)或SDHC(n = 2)突变的肿瘤。在所有SDHA缺陷型肿瘤中均发现了SDHA中的无义(n = 8)或错义(n = 1)突变。还从六名有可用材料的患者的正常组织的DNA中发现了杂合突变。在七个肿瘤中发现了第二个等位基因的体细胞丢失,其中五个因杂合性丧失而丢失,一个因13 bp缺失而丢失,一个因错义突变而丢失。 GIST中SDHA表达的丧失可靠地预测了SDHA突变的存在,这代表了成年人中SDH缺陷型GIST的相对常见原因。 SDHA的免疫组织化学可用于选择患者进行SDHA特异性基因检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号